Annual Accounts Receivable
$44.13 M
+$17.36 M+64.84%
December 31, 2023
Summary
- As of February 26, 2025, TLX annual accounts receivable is $44.13 million, with the most recent change of +$17.36 million (+64.84%) on December 31, 2023.
- During the last 3 years, TLX annual accounts receivable has risen by +$44.01 million (+35780.16%).
- TLX annual accounts receivable is now at all-time high.
Performance
TLX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$59.79 M
+$15.65 M+35.47%
June 1, 2024
Summary
- As of February 26, 2025, TLX quarterly accounts receivable is $59.79 million, with the most recent change of +$15.65 million (+35.47%) on June 1, 2024.
- Over the past year, TLX quarterly accounts receivable has stayed the same.
- TLX quarterly accounts receivable is now at all-time high.
Performance
TLX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TLX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +64.8% | 0.0% |
| 3 y3 years | +10000.0% | 0.0% |
| 5 y5 years | +9140.5% | +458.1% |
TLX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +8239.5% | at high | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Telix Pharmaceuticals Limited Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $59.79 M(+35.5%) |
| Dec 2023 | $44.13 M(+64.8%) | $44.13 M(+9.8%) |
| Jun 2023 | - | $40.20 M(+50.2%) |
| Dec 2022 | $26.77 M(+4959.1%) | $26.77 M(+130.2%) |
| Jun 2022 | - | $11.63 M(+2098.1%) |
| Dec 2021 | $529.20 K(+330.2%) | $529.20 K(-95.9%) |
| Jun 2021 | - | $12.93 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $123.00 K(-76.4%) | $123.00 K(-99.0%) |
| Jun 2020 | - | $11.97 M(+2194.9%) |
| Dec 2019 | - | $521.60 K(-95.1%) |
| Dec 2019 | $521.60 K(+9.2%) | - |
| Jun 2019 | - | $10.71 M(+2143.0%) |
| Dec 2018 | $477.60 K | $477.60 K(-85.6%) |
| Jun 2018 | - | $3.32 M |
FAQ
- What is Telix Pharmaceuticals Limited annual accounts receivable?
- What is the all time high annual accounts receivable for Telix Pharmaceuticals Limited?
- What is Telix Pharmaceuticals Limited annual accounts receivable year-on-year change?
- What is Telix Pharmaceuticals Limited quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Telix Pharmaceuticals Limited?
- What is Telix Pharmaceuticals Limited quarterly accounts receivable year-on-year change?
What is Telix Pharmaceuticals Limited annual accounts receivable?
The current annual accounts receivable of TLX is $44.13 M
What is the all time high annual accounts receivable for Telix Pharmaceuticals Limited?
Telix Pharmaceuticals Limited all-time high annual accounts receivable is $44.13 M
What is Telix Pharmaceuticals Limited annual accounts receivable year-on-year change?
Over the past year, TLX annual accounts receivable has changed by +$17.36 M (+64.84%)
What is Telix Pharmaceuticals Limited quarterly accounts receivable?
The current quarterly accounts receivable of TLX is $59.79 M
What is the all time high quarterly accounts receivable for Telix Pharmaceuticals Limited?
Telix Pharmaceuticals Limited all-time high quarterly accounts receivable is $59.79 M
What is Telix Pharmaceuticals Limited quarterly accounts receivable year-on-year change?
Over the past year, TLX quarterly accounts receivable has changed by $0.00 (0.00%)